Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...
ESPN's Bobby Marks laid out the landscape for L.A. in terms of its salary cap situation and what draft ... They can wait and see who hits the buyout market to add another reinforcement for the ...
In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Stocks must have a$ 30 million minimum market cap and a 5% minimum float ratio to be considered for inclusion. This required float ratio is lower than the 10% required by its index counterparts ...
Predicting a VIX spike is challenging. TMC Research’s VIX Risk Indicator tries to minimize this challenge by focusing on ...
When interest rates are low, small-cap stocks begin to shine and outpace larger companies in value. These stocks are stocks with a market capitalization between $300 million and $3 billion.
The index weights its final holdings by their float-adjusted market cap. It rebalances quarterly and reconstitutes annually. Market-cap weighting harnesses the market's collective wisdom of each ...
The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results